Journal Information
ISSN / EISSN : 00987484 / 15383598
Current Publisher: American Medical Association (AMA) (10.1001)
Total articles ≅ 250,158
Google Scholar h5-index: 209
Current Coverage
SCOPUS
PUBMED
MEDLINE
MEDICUS
SCIE
Archived in
SHERPA/ROMEO
EBSCO
Filter:

Latest articles in this journal

Scott D. Halpern, Robert D. Truog, Franklin G. Miller
Published: 29 June 2020
JAMA; doi:10.1001/jama.2020.11623

Kyle H. Sheetz, Nader N. Massarweh
Published: 29 June 2020
JAMA; doi:10.1001/jama.2020.2953

Abstract:
This Viewpoint discusses the rationale for centralizing high-risk surgical procedures—referring patients to medical centers with more experienced surgeons to im
David J. Eisenman
Published: 26 June 2020
JAMA; doi:10.1001/jama.2020.11489

Howard Bauchner, Phil B. Fontanarosa, Robert M. Golub
Published: 26 June 2020
JAMA; doi:10.1001/jama.2020.11764

Marcin Chwistek
Published: 25 June 2020
JAMA; doi:10.1001/jama.2020.10619

J. Matthew Austin, Allen Kachalia
Published: 25 June 2020
JAMA; doi:10.1001/jama.2020.11461

Michael L. Barnett, Lissy Hu, Thomas Martin, David C. Grabowski
Published: 24 June 2020
JAMA; doi:10.1001/jama.2020.11642

Abstract:
Mortality from coronavirus disease 2019 (COVID-19) is disproportionately concentrated in skilled nursing facilities (SNFs). As of June 18, 2020, 50 185 residents died of COVID-19 in the 41 states reporting deaths at SNFs, accounting for 45% of their total COVID-19 deaths statewide.1 In addition to long-term care, SNFs provide short-term care after elective surgeries and hospitalizations. With the decreases in hospital volume for elective surgeries and other services during the pandemic, SNF admissions may also be declining.2
Ameet Sarpatwari, Anna Kaltenboeck, Aaron S. Kesselheim
Published: 24 June 2020
JAMA; doi:10.1001/jama.2020.11932

Abstract:
This Viewpoint argues that the FDA’s Emergency Use Authorization (EUA) of remdesivir missed important opportunities to mandate further study of the drug’s safet
Douglas B. White, Derek C. Angus
Published: 24 June 2020
JAMA; doi:10.1001/jama.2020.11464

Abstract:
This Viewpoint proposes creation of state-level central lotteries for allocating drugs like remdesivir to hospitalized patients with COVID-19, which, if paired
Back to Top Top